Metformin IN Asthma for Overweight and Obese Individuals (MINA)

StatusRecruiting
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Sep 30, 2026 → Dec 31, 2026
See other at-risk trials from Johns Hopkins University

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Primary completion pushed from Sep 30, 2026 to Dec 31, 2026
    • Eligibility criteria expanded, about 15 words
  2. Minor Re-verified, no change to tracked fieldsv12
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    • Start date changed from estimate of Dec 15, 2024 to Dec 9, 2024
    v11
  4. Notable Start date: Oct 15, 2024 to Dec 15, 2024v10
  5. Notable Start date: Sep 15, 2024 to Oct 15, 2024v9
Show 7 earlier versionsHide 7 earlier versions
  1. Notable Start date: Aug 15, 2024 to Sep 15, 2024v8
  2. Notable Start date: Jul 1, 2024 to Aug 15, 2024v7
  3. Notable Start date: May 1, 2024 to Jul 1, 2024v6
  4. Notable Start date: Mar 1, 2024 to May 1, 2024v5
  5. Minor Eligibility criteria shortened, about 2 wordsv4
  6. Minor Secondary endpoints revised (5)v3
  7. Minor Secondary endpoints revised (5)v2
  1. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
3,888 trials monitored
See 157 trials at risk
958 trials monitored
See 36 trials at risk
This is a randomized clinical trial of metformin among overweight or obese adults with not well-controlled asthma despite maintenance inhaler therapy.
Trial Details
NCT Number NCT06273072
Lead Sponsor Johns Hopkins University
Collaborators: Baylor College of Medicine, National Heart, Lung, and Blood Institute (NHLBI), Temple University
Conditions
(from sponsor)
Asthma, Asthma Chronic, Overweight and Obesity
Related terms Asthma, Obesity, Overweight
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov